Defendant

NJOY unit

1 case as defendant.

Company profile

NJOY, LLC, commonly known as NJOY, is an American company specializing in the manufacture and distribution of electronic cigarettes and vaping products. Founded in 2007, the company is headquartered in Scottsdale, Arizona. Since June 2023, NJOY has been a wholly-owned subsidiary of Altria Group, Inc. (NYSE: MO), which acquired NJOY for approximately $2.75 billion. As of March 2026, NJOY reported an employee count of 126.

NJOY operates in the e-vapor industry, offering smoke-free nicotine alternatives to adult smokers. Its primary product lines include the NJOY ACE, a pod-based e-vapor device, and NJOY DAILY, a disposable electronic cigarette. Both the NJOY ACE and NJOY DAILY product lines have received market authorizations from the U.S. Food and Drug Administration (FDA) for both tobacco and menthol variants, affirming their compliance with regulatory standards.

Based on the provided case data, NJOY unit has a patent litigation posture as a defendant, with one tracked case. This indicates it is an operating company actively defending against intellectual property claims. The single tracked case, Juul Labs Inc. v. Altria et al., is before the U.S. International Trade Commission (ITC).

This particular ITC case is notable, as it resulted in a ruling in January 2025 that imported NJOY Ace devices and pods infringed on Juul Labs' patents, leading to a halt in their importation into the U.S. market. Beyond this, NJOY has a history of significant legal involvement, including a landmark 2010 lawsuit against the FDA that helped establish the regulatory framework for the electronic cigarette industry. More recently, in October 2023, NJOY initiated its own extensive litigation against 34 foreign and domestic entities, alleging the unlawful marketing and sale of illicit disposable e-vapor products.

Juul Labs Inc. v. Altria et al.

No Violation Found
Docket:
337-TA-1460
Filed:
2025-09-12
Terminated:
2026-04-14
Patents:12156533

Juul Labs Inc. initiated an ITC investigation against Altria and its NJOY unit, asserting US patent 12156533. The final initial determination found all asserted claims of the patent invalid, leading to a finding of no violation.